Behzad Hajarizadeh
Behzad Hajarizadeh
Viral Hepatitis Clinical Research Program, The Kirby Institute, The University of New South Wales
Verified email at - Homepage
Cited by
Cited by
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
Epidemiology and natural history of HCV infection
B Hajarizadeh, J Grebely, GJ Dore
Nature reviews Gastroenterology & hepatology 10 (9), 553-562, 2013
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression
R Waziry, B Hajarizadeh, J Grebely, J Amin, M Law, M Danta, J George, ...
Journal of hepatology 67 (6), 1204-1212, 2017
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
J Grebely, K Page, R Sacks‐Davis, MS van der Loeff, TM Rice, J Bruneau, ...
Hepatology 59 (1), 109-120, 2014
Hepatitis B Virus infection in Iran: A systematic review
SM Alavian, B Hajarizadeh, M AHMADZADASL, A Kabir, LK BAGHERI
HEPATITIS MONTHLY 8 (421), 281-294, 2008
Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study
SH MIRMOUMEN, SM Alavian, B Hajarizadeh, J Kafaei, B Yektaparast, ...
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ...
The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review
S Bajis, GJ Dore, B Hajarizadeh, EB Cunningham, L Maher, J Grebely
International Journal of Drug Policy 47, 34-46, 2017
Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis
B Hajarizadeh, EB Cunningham, H Reid, M Law, GJ Dore, J Grebely
The lancet Gastroenterology & hepatology 3 (11), 754-767, 2018
Direct-acting antiviral agents for HCV infection affecting people who inject drugs
J Grebely, B Hajarizadeh, GJ Dore
Nature reviews Gastroenterology & hepatology 14 (11), 641-651, 2017
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study
J Grebely, FMJ Lamoury, B Hajarizadeh, Y Mowat, AD Marshall, S Bajis, ...
The lancet Gastroenterology & hepatology 2 (7), 514-520, 2017
Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients
SM Alavian, B Einollahi, B Hajarizadeh, S Bakhtiari, M Nafar, S Ahrabi
Nephrology 8 (5), 256-260, 2003
Non‐alcoholic fatty liver disease prevalence among school‐aged children and adolescents in Iran and its association with biochemical and anthropometric measures
SM Alavian, AH Mohammad‐Alizadeh, F Esna‐Ashari, G Ardalan, ...
Liver international 29 (2), 159-163, 2009
Is tattooing a risk factor for hepatitis c transmission?: an updated systematic review and meta-analysis
M Khodadost, K Maajani, M Arabsalmani, N Mahdavi, R Tabrizi, ...
Hepatitis Monthly 17 (9), 2017
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection—the InC3 Study
R Sacks-Davis, InC3 study group, J Grebely, InC3 Study Group, GJ Dore, ...
The Journal of infectious diseases 212 (9), 1407-1419, 2015
The present and future disease burden of hepatitis C virus infections with today's treatment paradigm–volume 3
A Sibley, KH Han, A Abourached, LA Lesmana, M Makara, W Jafri, ...
Journal of viral hepatitis 22, 21-41, 2015
Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 3
V Liakina, S Hamid, J Tanaka, S Olafsson, AI Sharara, SM Alavian, ...
Journal of viral hepatitis 22, 4-20, 2015
Hepatitis C treatment as prevention: evidence, feasibility, and challenges
B Hajarizadeh, J Grebely, M Martinello, GV Matthews, AR Lloyd, GJ Dore
The lancet Gastroenterology & hepatology 1 (4), 317-327, 2016
Chronic hepatitis C burden and care cascade in Australia in the era of interferon‐based treatment
B Hajarizadeh, J Grebely, H McManus, C Estes, H Razavi, RT Gray, ...
Journal of gastroenterology and hepatology 32 (1), 229-236, 2017
The system can't perform the operation now. Try again later.
Articles 1–20